M. C. CarreÇo, M. Ribagorda et al.
28.3 ppm; MS (ES): m/z (%): 181.12 (3) [M+1]+; HRMS: m/z calcd for
C8H9BO4: 180.0594 [M+1]+; found: 181.1219.
Compound 10:[61] Following the above procedure, purification by flash
column chromatography gave 10 (76 mg, 71%) as a yellow solid. M.p.
141–1438C.
Compound 7a: Following the general procedure B, the reaction of 4a
(60 mg, 0.26 mmol) with CAN (339 mg, 0.62 mmol) in aqueous MeCN
gave 7a as an orange solid (51 mg, 100%). M.p. 106–1088C; 1H NMR
(300 MHz, [D6]acetone): d=8.14–8.08 (m, 2H), 7.81–7.78 (m, 2H), 7.58
(s, 1H), 6.25 ppm (s, 2H); 13C NMR (75 MHz, [D6]acetone): d=190.9,
184.7, 145.9, 134.2, 134.0, 132.4, 132.3, 126.2, 125.7 ppm; 11B NMR
(96 MHz, [D6]acetone): d=27.8 ppm; MS (ES): m/z (%): 203 (25)
[M+1]+, 189 (29), 61 (100); HRMS: m/z calcd for C10H7BO4: 202.0437
[M]+; found: 202.0550.
Compound 11a: Following the general procedure C, the reaction of 7a
(60 mg, 0.30 mmol) with trans-piperylene (0.12 mL, 1.2 mmol) gave 11a
as a pale yellow solid (55 mg, 83%). Reaction time: 30 min, T: À208C.
M.p. 68–708C; 1H NMR (300 MHz, CDCl3): d=8.11–8.06 (m, 2H), 7.75–
7.70 (m, 2H), 5.85 (m, 2H), 3.64 (m, 1H), 3.35 (ddd, J=24.5, 5.0, 3.6 Hz,
1H), 3.35 (ddd, J=24.5, 6.3, 2.4 Hz, 1H), 1.26 ppm (s, 1H); 13C NMR
(75MHz, CDCl3): d=184.7, 184.2, 146.5, 141.7, 133.5, 133.4, 132.3, 132.0,
130.0, 126.3, 126.1, 121.3, 29.3, 24.6, 22.0 ppm; MS (EI): m/z (%): 224
(51) [M]+, 222 (63), 209 (100); HRMS: m/z calcd for C15H12O2: 224.0837
[M]+; found: 224.0834.
Compound 11b:[61] Following the general procedure C, the reaction of
7b (110 mg, 0.47 mmol) with trans-piperylene (129 mL, 1,90 mmol) gave
11b after flash column chromatography (hexane/EtOAc, 6:1) as a yellow
solid. (110 mg, 91%). Reaction time: 120 min, T: À208C. M.p. 138–
1408C.
Compound 7b: Following the general procedure B, the reaction of 4b
(94 mg, 0.360 mmol) with CAN (473 mg, 0.864 mmol) in aqueous MeCN
gave 7b as an orange solid (53 mg, 63%). M.p. decomposes above
1408C; 1H NMR (300 MHz, CDCl3): d=7.77–7.69 (m, 2H), 7.44 (s, 1H),
7.34 (dd, J=7.9, 1.0 Hz, 1H), 6.25 (brs, 2H), 4.02 ppm (s, 3H); 13C NMR
(75 MHz, CDCl3): d=191.5, 184.3, 159.6, 149.8, 135.2, 134.2, 120.2, 119.4,
118.3, 56.5 ppm; 11B NMR (96 MHz, CDCl3): d=27.5 ppm; MS (ES): m/z
(%): 227 (100), 205 (40); HRMS: m/z calcd for C11H7O3: 187.0395 [M]+;
found: 187.0606.
Compound 12a: Following the general procedure C, the reaction of 7a
(40 mg, 0.19 mmol) with isoprene (75 mL, 0.76 mmol) gave 12a as a
white solid (41 mg, 96%). Reaction time: 2 h, T: 258C. M.p. 124–1268C;
1H NMR (300 MHz, CDCl3): d=8.12–8.08 (m, 2H), 7.73–7.70 (m, 2H),
5.57–5.54 (m, 1H), 3.29–3.22 (m, 2H), 3.17–3.11 (m, 2H), 1.82 ppm (s,
3H); 13C NMR (75 MHz, CDCl3): d=184.6, 184.5, 141.8, 141.6, 133.5,
132.1, 132.1, 132.0, 130.1, 126.4, 126.2, 116.8, 26.1, 26.6, 22.9 ppm; MS
(EI): m/z (%): 224 (2) [M]+, 223 (17), 194 (63), 166 (39), 165 (100);
HRMS: m/z calcd for C15H12O2: 224.0837 [M]+; found: 224.0713.
Compound 7c: Following the general procedure B, the reaction of 4c
(50 mg, 0.14 mmol) with CAN (183 mg, 0.33 mmol) in aqueous MeCN
gave 7c as an orange solid (46 mg, 100%). M.p. 136–1388C; 1H NMR
(300 MHz, CDCl3): d=8.14–8.07 (m, 2H), 7.84–7.78 (m, 2H), 6.96 (brs,
2H), 3.52 (sept, J=6.8 Hz, 2H), 3.52 (sept, J=6.8 Hz, 2H), 3.46 (d, J=
6.8 Hz, 6H), 1.19 ppm (d, J=6.8 Hz, 6H); 13C NMR (75 MHz, CDCl3):
d=191.1, 182.7, 165.7, 152.2, 134.5 (2C), 132.2, 131.3, 126.7, 126.5, 52.0,
46.6, 20.0 (2C), 19.9 ppm (2C); 11B NMR (96 MHz, CDCl3): d=28.2 ppm;
MS (ES): m/z (%): 329 (7) [M]+, 330 (100) [M+1]+; HRMS: m/z calcd
for C10H7BO4: 329.1435 [M]+; found: 329.1558.
Compound 12b: Following the general procedure C, the reaction of 7b
(30 mg, 0.13 mmol) with isoprene (39 mL, 0.39 mmol) gave 12b after
flash column chromatography (hexane/EtOAc, 10:1) as an orange solid
(22 mg, 67%). Reaction time: 2.5 h, T: 258C. M.p. 144–1468C; 1H NMR
(300 MHz, CDCl3): d=7.75 (dd, J=7.6, 0.9 Hz, 1H), 7.64 (t, J=8.0 Hz,
1H), 7.27 (dd, J=8.4, 0.8 Hz, 1H), 5.61–5.44 (m, 1H), 4.01 (s, 3H), 3.19
(m, 2H), 3.10 (m, 2H), 1.80 ppm (s, 3H); 13C NMR (75 MHz, CDCl3):
d=184.7, 183.8, 159.4, 143.3, 139.5, 134.4, 134.3, 130.3, 120.0, 119.0, 117.5,
116.7, 56.4, 29.2, 25.3, 22.9 ppm. MS (EI): m/z (%): 254 (2) [M]+, 252
(98), 165 (100), 152 (41); HRMS: m/z calcd for C16H14O3: 254.0953 [M]+;
found: 254.0959.
General procedure C for Diels–Alder reactions: The appropriate diene
(0.6–0.8 mmol) was added to a solution of the corresponding 2-benzo- or
naphthoquinonylboronic acid (0.2 mmol) in CH2Cl2 (3 mL). The resulting
mixture was stirred at temperature T during the time indicated in each
case. Water (3 mL) was added and the mixture was extracted with
CH2Cl2 (3ꢅ3 mL). The combined organic layers were dried over MgSO4,
filtered and the solvent was removed in vacuo.
Compound 24d: Following the general procedure C, the reaction of 7d
(35 mg, 0.16 mmol) with 2-[(tert-butyldimethylsilyl)oxy]-4-phenyl-1,3-bu-
tadiene (59 mg, 0.23 mmol) gave 24d after flash column chromatography
(hexane/EtOAc, 50:1) as a colourless oil (57 mg, 81%). Reaction time:
30 min, T: À208C. 1H NMR (300 MHz, CDCl3): d=8.01–7.97 (m, 1H),
7.75–7.70 (m, 1H), 7.65–7.53 (m, 2H), 7.34 (brs, 1H) 7.32 (brs, 1H),
7.25–7.16 (m, 2H), 7.14–7.08 (m, 1H), 4.09 (t, J=2.4 Hz, 1H), 3.24 (d,
J=9.8 Hz, 1H), 2.82 (d, J=17.7 Hz, 1H), 2.28 (dd, J=17.7, 1.1 Hz, 1H),
1.25 (s, 3H), 0.87 (s, 9H), 0.09 (s, 3H), 0.08 ppm (s, 3H); 13C NMR
(75 MHz, CDCl3: d=200.7, 197.1, 147.4, 145.2, 136.1, 134.24, 133.9, 132.5,
128.9, 128.2, 127.3, 126.3, 126.2, 106.8, 57.2, 50.1, 39.3, 37.9, 25.6, 20.4,
18.0, À4.1, À4.34 ppm; MS (EI): m/z (%): 433 (100) [M+1]+, 315 (100);
HRMS: m/z calcd for C27H33O3Si: 433.2199 [M]+; found: 433.1990.
Compound 9a:[60] Following the general procedure C, the reaction of 7a
(60 mg, 0.30 mmol) with cyclopentadiene (98 mL, 1.18 mmol) gave 9a as
a pale yellow solid (67 mg, 100%). Reaction time: 20 min, T: À208C.
Compound 9c: Following the general procedure C, the reaction of 7c
(40 mg, 0.12 mmol) with cyclopentadiene (41 mL, 0.48 mmol) gave 9c as
a pale yellow solid (35 mg, 82%). Reaction time: 15 h, T: À208C. M.p.
120–1228C; 1H NMR (300 MHz, CDCl3): d=8.02–7.94 (m, 2H), 7.71–
7.68 (m, 2H), 5.86 (brs, 2H), 3.92 (brs, 1H), 3.51 (sept, J=6.4 Hz, 1H),
3.43 (m, 1H), 3.35 (d, J=3.5 Hz, 1H), 3.27 (sept, J=6.4 Hz, 1H), 1.81 (d,
J=13.7 Hz, 1H), 1.61 (d, J=13.7 Hz, 1H), 1.47 (d, J=7.3 Hz, 3H), 1.38
(d, J=7.3 Hz, 3H), 1.00 (d, J=6.4 Hz, 3H), 0.68 ppm (d, J=6.4 Hz, 3H);
13C NMR (75 MHz, CDCl3): d=197.1, 194.1, 169.3, 137.7, 135.6, 135.1,
134.5, 134.2, 126.9, 126.7, 64.6, 56.5, 56.1, 50.9 (2C), 48.5, 46.5, 29.6, 20.2
(2C), 20.0, 18.7 ppm; MS (EI): m/z (%): 351.2 (8.5) [M]+, 285 (56), 185
(56), 200 (100); HRMS: m/z calcd for C22H25NO3: 351.1834 [M]+; found:
351.1819.
Compound 25d: Following the general procedure C, the reaction of 7d
(26 mg, 0.12 mmol) with 1-(1-cyclohexenyl)-1-[(tert-butyldimethylsilyl)oxy]-
ethene (40 mg, 0.17 mmol) gave 25d after flash column chromatography
(hexane/EtOAc, 55:1) as a colourless oil (37 mg, 75%). Reaction time:
5 min, T: À208C. 1H NMR (300 MHz, CDCl3): d=8.10–8.02 (m, 1H),
7.98–7.91 (m, 1H), 7.75–7.69 (m, 2H), 2.97 (m, 1H), 2.83–2.65 (m, 3H),
2.35–2.23 (m, 2H), 1.84–1.72 (m, 2H), 1.65–1.45 (m, 2H), 1.31–1.18 (m,
1H), 1.16 (s, 3H), 0.98 (s, 9H), 0.87–0.75 (m, 1H), 0.17 ppm (brs, 6H);
13C NMR (75 MHz, CDCl3: d=201.1, 198.1, 137.9, 136.3, 134.1, 133.9,
132.7, 127.3, 126.0, 115.8, 56.6, 48.7, 38.2, 35.3, 34.6, 26.7, 26.1, 25.9, 25.8,
20.2, 18.2, À3.7, À3.8 ppm; MS (FAB+): m/z (%): 410 (100) [M]+, 409
(58), 353 (29); HRMS: m/z calcd for C25H32O4Si: 410.2277 [M]+, found:
410.2286.
Compound 9b: Following the general procedure C, the reaction of 7b
(100 mg, 0.43 mmol) with cyclopentadiene (142 mL, 1.72 mmol) gave a
18:82 mixture of 9b and 10. Reaction time: 50 min, T: À208C. Purifica-
tion by flash column chromatography (hexane/EtOAc, 5:1) gave 9b as a
yellow oil (14 mg, 13%) 1H NMR (300 MHz, CDCl3): d=7.61–7.52 (m,
2H), 7.20 (dd, J=8.0, 1.6 Hz , 1H), 6.05 (dd, J=5.9, 3.0 Hz, 1H), 5.98
(dd, J=5.9, 3.0 Hz, 1H), 3.93 (s, 3H), 3.62–3.55 (m, 2H), 3.47–3.44 (m,
2H), 1.56 (dt, J=8.7, 1.7 Hz
, 1H), 1.48 ppm (d, J=8.7 Hz, 1H);
13C NMR (75 MHz, CDCl3): d=198.5, 197.0, 158.9, 136.3, 135.5, 134.6,
118.8, 117.1, 56.4, 51.4, 50.3, 48.8, 48.4, 48.1 ppm; MS (EI): m/z (%): 254
(9) [M]+, 240 (20), 66 (100); HRMS: m/z calcd for C16H14O3: 254.0943
[M]+; found: 254.0481.
Compound (26d): Following the general procedure C, the reaction of 7d
(28 mg, 0.13 mmol) with 2-[(tert-butyldimethylsilyl)oxy]-3,4-dimethyl-1,3-
butadiene (39 mg, 0.18 mmol) gave 26d after flash column chromatogra-
phy (hexane/EtOAc, 55:1) as a colourless oil (36 mg, 72%). Reaction
3716
ꢃ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 3707 – 3719